Company: STAA
Filing Date: 2025-10-17
Form Type: DFAN14A
Source: 0001213900-25-100009
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-10-17
Form: DFAN14A
Chunk 1
---
 any adjournments, postponements, reschedulings or continuations thereof, the “Special
Meeting”). The Participants have filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”)
and accompanying GREEN Proxy Card to be used in connection with any such solicitation of proxies from the Company’s
stockholders for the Special Meeting. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS HAVE FILED OR WILL FILE WITH THE U.S. SECURTIES AND EXCHANGE COMMISSION (THE “SEC”) BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING AND additional information relating to the Participants and their direct or indirect interests, by security holdings or otherwise. The Definitive Proxy Statement and accompanying GREEN Proxy
Card have been furnished to some or all of the Company’s stockholders and will be, along with other relevant documents, available
at no charge on the SEC’s website at https://www.sec.gov/.

Information about the Participants and a description of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants with the SEC on September 26, 2025 and is available here.

Exhibit 1

<div align='center'>Broadwood Partners Issues Letter to STAAR Surgical’s Board Urging it to Allow Timely Shareholder Vote on Alcon Sale

Calls on Board to Avoid Temptation to Delay Meeting or Further Mislead Shareholders

Broadwood Continues to Urge Shareholders to Vote “ AGAINST” Proposed Transaction</div>

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates
(collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR
Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR’s outstanding
common shares, urges its fellow shareholders to vote on its GREEN Proxy Card “AGAINST”
the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC) on the terms announced on August 5, 2025.

Shareholders can find additional information at www.LetSTAARSh